Comcast New (CMCSA) Share Value Declined While Aspiriant Has Decreased Its Position by $2.39 Million; As Gilead Sciences (GILD) Stock Price Rose, Healthcare Value Capital Boosted Holding

April 17, 2018 - By Peter Erickson

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Healthcare Value Capital Llc increased its stake in Gilead Sciences Inc (GILD) by 25% based on its latest 2017Q4 regulatory filing with the SEC. Healthcare Value Capital Llc bought 15,000 shares as the company’s stock rose 1.93% while stock markets declined. The hedge fund held 75,000 shares of the health care company at the end of 2017Q4, valued at $5.37M, up from 60,000 at the end of the previous reported quarter. Healthcare Value Capital Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $97.39B market cap company. The stock decreased 0.70% or $0.53 during the last trading session, reaching $74.69. About 4.24M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since April 17, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Aspiriant Llc decreased its stake in Comcast Corp New (CMCSA) by 85.89% based on its latest 2017Q4 regulatory filing with the SEC. Aspiriant Llc sold 59,692 shares as the company’s stock declined 19.10% with the market. The institutional investor held 9,807 shares of the television services company at the end of 2017Q4, valued at $393,000, down from 69,499 at the end of the previous reported quarter. Aspiriant Llc who had been investing in Comcast Corp New for a number of months, seems to be less bullish one the $155.73 billion market cap company. The stock increased 1.54% or $0.51 during the last trading session, reaching $33.53. About 13.80M shares traded. Comcast Corporation (NASDAQ:CMCSA) has declined 11.10% since April 17, 2017 and is downtrending. It has underperformed by 22.65% the S&P500.

Investors sentiment decreased to 0.93 in Q4 2017. Its down 0.10, from 1.03 in 2017Q3. It turned negative, as 75 investors sold CMCSA shares while 544 reduced holdings. 122 funds opened positions while 455 raised stakes. 3.66 billion shares or 0.28% more from 3.65 billion shares in 2017Q3 were reported. Schroder Investment Grp Incorporated invested 0.29% of its portfolio in Comcast Corporation (NASDAQ:CMCSA). Cibc Fincl Bank Usa stated it has 0.24% in Comcast Corporation (NASDAQ:CMCSA). Frontier Inv Mngmt owns 392,523 shares for 1.31% of their portfolio. Hartford Investment Management reported 0.76% in Comcast Corporation (NASDAQ:CMCSA). Boyd Watterson Asset Mngmt Ltd Oh owns 15,287 shares or 0.3% of their US portfolio. Dana Invest Advsr Inc has 729,804 shares. Chicago Equity Ptnrs Ltd Liability Com owns 417,140 shares. 1St Source Fincl Bank holds 0.07% or 21,265 shares. Cypress Asset Mgmt Incorporated Tx has 0.07% invested in Comcast Corporation (NASDAQ:CMCSA). Steinberg Asset Mgmt accumulated 0.1% or 16,577 shares. 7,314 were reported by Chartist Inc Ca. Busey Tru stated it has 0.04% of its portfolio in Comcast Corporation (NASDAQ:CMCSA). 2,124 are held by Oakworth Cap Incorporated. Wellington Shields Cap Mngmt Ltd holds 0.56% or 90,239 shares in its portfolio. Hbk Investments LP has invested 0.54% of its portfolio in Comcast Corporation (NASDAQ:CMCSA).

Among 32 analysts covering Comcast Corporation (NASDAQ:CMCSA), 23 have Buy rating, 1 Sell and 8 Hold. Therefore 72% are positive. Comcast Corporation had 82 analyst reports since July 27, 2015 according to SRatingsIntel. Goldman Sachs maintained the stock with “Buy” rating in Wednesday, May 4 report. The stock of Comcast Corporation (NASDAQ:CMCSA) earned “Neutral” rating by Instinet on Thursday, January 18. The firm earned “Buy” rating on Thursday, January 25 by Jefferies. The firm has “Buy” rating by SunTrust given on Thursday, October 26. The rating was maintained by Buckingham Research with “Buy” on Monday, January 8. The firm has “Neutral” rating by Macquarie Research given on Monday, January 4. The stock has “Overweight” rating by Barclays Capital on Friday, October 27. RBC Capital Markets maintained the stock with “Outperform” rating in Tuesday, January 31 report. RBC Capital Markets maintained Comcast Corporation (NASDAQ:CMCSA) on Thursday, April 28 with “Outperform” rating. The stock of Comcast Corporation (NASDAQ:CMCSA) earned “Buy” rating by RBC Capital Markets on Friday, July 7.

Analysts await Comcast Corporation (NASDAQ:CMCSA) to report earnings on April, 25 before the open. They expect $0.59 EPS, up 11.32% or $0.06 from last year’s $0.53 per share. CMCSA’s profit will be $2.74 billion for 14.21 P/E if the $0.59 EPS becomes a reality. After $0.49 actual EPS reported by Comcast Corporation for the previous quarter, Wall Street now forecasts 20.41% EPS growth.

Since December 14, 2017, it had 0 insider buys, and 10 selling transactions for $62.55 million activity. On Monday, December 18 BLOCK ARTHUR R sold $224,575 worth of Comcast Corporation (NASDAQ:CMCSA) or 5,630 shares. 583,835 Comcast Corporation (NASDAQ:CMCSA) shares with value of $22.57M were sold by ROBERTS BRIAN L. Another trade for 1,891 shares valued at $67,320 was sold by Murdock Daniel C.. WATSON DAVID N sold $4.84 million worth of Comcast Corporation (NASDAQ:CMCSA) on Tuesday, March 6.

Aspiriant Llc, which manages about $8.09 billion and $340.65 million US Long portfolio, upped its stake in Ubs Ag London Brh (AMU) by 32,897 shares to 228,538 shares, valued at $3.96M in 2017Q4, according to the filing.

Since January 2, 2018, it had 0 buys, and 17 selling transactions for $39.51 million activity. MARTIN JOHN C also sold $3.93 million worth of Gilead Sciences, Inc. (NASDAQ:GILD) shares. Shares for $2.37 million were sold by Alton Gregg H on Thursday, January 11. The insider Meyers James R sold 100,000 shares worth $8.02 million. On Wednesday, February 21 the insider Washington Robin L sold $401,566. On Friday, February 9 WILSON GAYLE E sold $4.68M worth of Gilead Sciences, Inc. (NASDAQ:GILD) or 60,000 shares.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 126 analyst reports since July 29, 2015 according to SRatingsIntel. Leerink Swann maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Thursday, February 22. Leerink Swann has “Hold” rating and $80.0 target. The firm has “Buy” rating by Jefferies given on Friday, January 26. As per Tuesday, January 30, the company rating was upgraded by Citigroup. Berenberg initiated the stock with “Buy” rating in Thursday, September 22 report. As per Wednesday, June 14, the company rating was maintained by William Blair. The rating was maintained by Piper Jaffray on Wednesday, February 3 with “Overweight”. The firm has “Overweight” rating given on Friday, July 24 by Piper Jaffray. The firm has “Outperform” rating given on Wednesday, November 2 by RBC Capital Markets. On Monday, October 3 the stock rating was maintained by RBC Capital Markets with “Outperform”. Mizuho maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Tuesday, July 25. Mizuho has “Buy” rating and $7700 target.

Comcast Corporation (NASDAQ:CMCSA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Peter Erickson

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: